BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25818750)

  • 1. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
    Vlahos R; Bozinovski S
    Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.
    Vlahos R; Bozinovski S
    Methods Mol Biol; 2018; 1725():53-63. PubMed ID: 29322408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Lung Inflammation and Pathology in Preclinical Models of Chronic Obstructive Pulmonary Disease.
    Vlahos R; Wang H; Bozinovski S
    Methods Mol Biol; 2023; 2691():97-109. PubMed ID: 37355540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in pre-clinical mouse models of COPD.
    Vlahos R; Bozinovski S
    Clin Sci (Lond); 2014 Feb; 126(4):253-65. PubMed ID: 24144354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of chronic obstructive pulmonary disease.
    Fricker M; Deane A; Hansbro PM
    Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
    Vlahos R; Bozinovski S; Hamilton JA; Anderson GP
    Pharmacol Ther; 2006 Oct; 112(1):106-15. PubMed ID: 16716406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease.
    Shergis JL; Di YM; Zhang AL; Vlahos R; Helliwell R; Ye JM; Xue CC
    Complement Ther Med; 2014 Oct; 22(5):944-53. PubMed ID: 25440386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling COPD in mice.
    Vlahos R; Bozinovski S; Gualano RC; Ernst M; Anderson GP
    Pulm Pharmacol Ther; 2006; 19(1):12-7. PubMed ID: 16286233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
    Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
    Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of chronic obstructive pulmonary disease exacerbations.
    Gaschler GJ; Bauer CMT; Zavitz CCJ; Stämpfli MR
    Contrib Microbiol; 2007; 14():126-141. PubMed ID: 17684337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
    Bernardo I; Bozinovski S; Vlahos R
    Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway bacterial colonization: the missing link between COPD and cardiovascular events?
    Fuschillo S; Martucci M; Donner CF; Balzano G
    Respir Med; 2012 Jul; 106(7):915-23. PubMed ID: 22546638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of COPD.
    Spurzem JR; Rennard SI
    Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts.
    Chhabra SK; Dash DJ
    Indian J Chest Dis Allied Sci; 2014; 56(2):93-104. PubMed ID: 25230550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts in chronic obstructive pulmonary disease.
    Barnes PJ
    Annu Rev Med; 2003; 54():113-29. PubMed ID: 12359824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD and stroke: are systemic inflammation and oxidative stress the missing links?
    Austin V; Crack PJ; Bozinovski S; Miller AA; Vlahos R
    Clin Sci (Lond); 2016 Jul; 130(13):1039-50. PubMed ID: 27215677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER; Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.
    Stevenson CS; Birrell MA
    Pharmacol Ther; 2011 May; 130(2):93-105. PubMed ID: 21074553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations.
    Mallia P; Johnston SL
    Proc Am Thorac Soc; 2005; 2(4):361-6; discussion 371-2. PubMed ID: 16267363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.